Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Nylon L.E. 0.20 ìm, 13 mm Dia.

Product Description
NYLON LOW EXTRACTABLES (LE)
• Superior to Nylon 66 membranes
• Nylon-LE is a unique unsupported Nylon membrane
• Does not release significant levels of extractables when in contact with acetonitrile
• Suitable for use with any HPLC sample or solvent
• The elimination of the polyester support in these Q-Fil filters, combined with the unique surface characteristics of this new membrane, eliminates many of the extractables found in Nylon membranes and results in a much cleaner filtrate

The Q-Fil range of Certified Syringe Filters set the new Quality standard for today’s laboratory syringe filters.
Manufactured from the highest quality medical grade high density polypropylene Q-Fil Certified Syringe Filters provide excellent chemical compatibility with acids, alcohols, bases, ethers, glycols, ketones and oils, with maximum operating temperatures of 135°C.
Every colour-coded filter is printed with the individual batch number, details of the membrane material and its pore size, on the outside rim of the filter, making them unique for traceability, GLPs and validation purposes.
Q-Fil Certified Syringe Filters -
• Manufactured in compliance with ISO 9001:2000 quality procedures.
• Are supplied with a Certificate of Analysis and Conformance to guarantee its batch to batch quality and performance.
• Are available in the most popular sizes, porosities and membrane types.
• Provide excellent resistance to all routinely used HPLC solvents.
• Have filter housings manufactured from high density medical grade polypropylene.
• Contain extremely low level of extractables for highly sensitive work.
• Luer connections fully comply with ISO 594-1.
• Filters are available with standard and 'Slim Tip' sized outlets.

To view Greyhound Chromatography's full range of Syringe Filrers please visit www.greyhound.com
Product Nylon L.E. 0.20 ìm, 13 mm Dia.
Company Greyhound Chromatography - Products
Price Request a quote
More Information View company product page
Catalog Number 40-100013
Quantity 100
Company Logo

Greyhound Chromatography - Products
Greyhound Chromatography and Allied Chemicals, 6 Kelvin Park, Birkenhead, Merseyside, United Kingdom CH41 1LT

Tel: +44 151 649 4000
Fax: +44 151 649 4001
Email: sales@greyhoundchrom.com



Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!